Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Endra Life Sciences Inc (NDRA)

Endra Life Sciences Inc (NDRA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 99,227
  • Shares Outstanding, K 37,586
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,310 K
  • 60-Month Beta 1.28
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 18.35
Trade NDRA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.14
  • Number of Estimates 1
  • High Estimate -0.14
  • Low Estimate -0.14
  • Prior Year -1.20
  • Growth Rate Est. (year over year) +88.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.60 +65.00%
on 02/23/21
2.99 -11.71%
on 02/16/21
+0.62 (+30.69%)
since 02/01/21
3-Month
0.70 +275.53%
on 12/22/20
2.99 -11.71%
on 02/16/21
+1.79 (+210.73%)
since 12/01/20
52-Week
0.60 +340.73%
on 04/06/20
2.99 -11.71%
on 02/16/21
+1.54 (+140.22%)
since 02/28/20

Most Recent Stories

More News
ENDRA Life Sciences Announces New Clinical Study Partnership with Inselspital University Hospital in Bern, Switzerland

Study to Bolster Clinical Performance Evidence of TAEUS® Ultrasound Device in NAFLD Patients as Commercialization Begins

NDRA : 2.64 (+5.60%)
Thinking about buying stock in Salarius Pharmaceuticals, KemPharm, Ocular Therapeutix, Boxlight Corp, or Endra Life Sciences?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SLRX, KMPH, OCUL, BOXL, and NDRA.

KMPH : 9.80 (+3.38%)
OCUL : 19.46 (+6.11%)
SLRX : 1.9700 (+9.44%)
BOXL : 3.03 (+8.99%)
NDRA : 2.64 (+5.60%)
ENDRA Life Sciences Further Strengthens TAEUS(R) System Intellectual Property Protection with Issuance of 14th U.S. Patent

ANN ARBOR, MI / ACCESSWIRE / January 26, 2021 / (''ENDRA'') (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), has recently been issued U.S. Patent 10898166 (the '166 patent) from...

NDRA : 2.64 (+5.60%)
Thinking about buying stock in Palatin Technologies, Motus GI Holdings, Tellurian, OncoCyte, or Endra Life Sciences?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PTN, MOTS, TELL, OCX, and NDRA.

OCX : 4.88 (-0.81%)
PTN : 0.8044 (+2.86%)
MOTS : 1.5100 (+4.14%)
NDRA : 2.64 (+5.60%)
TELL : 3.00 (-2.91%)
Thinking about buying stock in Dare Bioscience, Endra Life Sciences, Lineage Cell Therapeutics, Inuvo Inc, or eMagin Corp?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DARE, NDRA, LCTX, INUV, and EMAN.

EMAN : 4.52 (+18.02%)
INUV : 1.3100 (+23.58%)
LCTX : 2.41 (+4.78%)
DARE : 1.9900 (+6.42%)
NDRA : 2.64 (+5.60%)
Thinking about buying stock in DBV Technologies, Endra Life Sciences, Precision BioSciences, Sorrento Therapeutics, or Aldeyra Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DBVT, NDRA, DTIL, SRNE, and ALDX.

DBVT : 5.46 (+2.06%)
DTIL : 12.87 (+7.61%)
ALDX : 12.20 (-0.49%)
NDRA : 2.64 (+5.60%)
SRNE : 10.25 (+6.00%)
ENDRA Life Sciences Granted 13th U.S. Patent for its TAEUS(R) Platform Technology

Now Has 78 Patents Issued, Filed, Licensed or in Preparation As Taeus® Commercial Launch Plans Advance

NDRA : 2.64 (+5.60%)
ENDRA Life Sciences to Present at H.C. Wainwright Virtual BioConnect 2021 Conference

ANN ARBOR, MI / ACCESSWIRE / January 8, 2021 / (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that Chairman and CEO Francois Michelon will present at the...

NDRA : 2.64 (+5.60%)
ENDRA Life Sciences Issued Chinese Patent for Its TAEUS(R) Platform Technology to Calculate Fat Concentration in Tissue

ANN ARBOR, MI / ACCESSWIRE / December 23, 2020 / (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), has recently been issued Chinese Patent ZL 2018 8 00500526 (the '526...

NDRA : 2.64 (+5.60%)
ENDRA Life Sciences Extends GE Healthcare Collaboration Agreement for Two Years

Supports Commercialization of TAEUSa" Product for Imaging NAFLD/NASH to December 2023

GE : 13.11 (+4.55%)
NDRA : 2.64 (+5.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States.

See More

Key Turning Points

3rd Resistance Point 2.96
2nd Resistance Point 2.83
1st Resistance Point 2.73
Last Price 2.64
1st Support Level 2.50
2nd Support Level 2.37
3rd Support Level 2.27

See More

52-Week High 2.99
Last Price 2.64
Fibonacci 61.8% 2.08
Fibonacci 50% 1.79
Fibonacci 38.2% 1.51
52-Week Low 0.60

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar